EnVivo Pharmaceuticals
Latest round
- Series C
Last raised
- Sep 2006
Total raised
- $43M
Investors
- 6
About EnVivo Pharmaceuticals
EnVivo Pharmaceuticals Inc. is a US-based company that operates as a developer of small molecule therapeutics for the disorders of the central nervous system.
Who invested in EnVivo Pharmaceuticals
6 investors across 3 rounds
See all investors in EnVivo Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about EnVivo Pharmaceuticals
Who invested in EnVivo Pharmaceuticals?
EnVivo Pharmaceuticals has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has EnVivo Pharmaceuticals raised?
EnVivo Pharmaceuticals has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did EnVivo Pharmaceuticals last raise money?
EnVivo Pharmaceuticals's most recent round on record is a Series C, in Sep 2006.
What does EnVivo Pharmaceuticals do?
EnVivo Pharmaceuticals is a biotechnology company.
Where is EnVivo Pharmaceuticals headquartered?
EnVivo Pharmaceuticals is headquartered in Watertown, US.
Which VCs invest in companies like EnVivo Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at EnVivo Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like EnVivo Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.